Digitalis for treatment of heart failure in patients in sinus rhythm (Q24247158)

4

object named as

Roman Jaeschke

0 references

author name string

William B Hood, Jr.

1

0 references

Antonio L Dans

2

0 references

John JV McMurray

Cochrane Database of Systematic Reviews

5

0 references

publication date

19 April 2004

0 references

published in

0 references

cites work

Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease: a randomized, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Nonpharmacologic therapy improves functional and emotional status in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effect of digitalis treatment on survival after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

The functional defect in amyloid heart disease. The "stiff heart" syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

The effect of gender on outcome in digitalis-treated heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Digoxin. A neurohormonal modulator in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Cardiac glycosides in the next millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Is maintenance digoxin necessary in patients with sinus rhythm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

The effect of digoxin on the quality of life in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Favorable effects of orally administered digoxin on left heart size and ventricular wall motion in patients with previous myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Digitalis: new actions for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Exercise capacity and quality of life in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

The effect of digoxin on mortality and morbidity in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

A controlled trial of digoxin in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Heart failure in outpatients: a randomized trial of digoxin versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Digoxin Withdrawal After Cardiac Failure in Patients with Sinus Rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Clinical predictors of worsening heart failure during withdrawal from digoxin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Clinical benefits of low serum digoxin concentrations in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Long-term digitalis therapy improves left ventricular function in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Association of digitalis therapy with mortality in survivors of acute myocardial infarction: observations in the Beta-Blocker Heart Attack Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Maintenance Digoxin in Elderly Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Digoxin in eurhythmic heart failure: PROVED or "not proven"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effect of chronic oral digoxin therapy on ventricular function at rest and peak exercise in patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

The efficacy of digitalis withdrawal in an institutional aged population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Reconsidering the role for digoxin in the management of acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Digitalis-associated cardiac mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Sex-based differences in the effect of digoxin for the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Association of serum digoxin concentration and outcomes in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Blind study on the action of digitoxin on elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Low-dose digoxin in patients with heart failure. Less toxic and at least as effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2

Short- and long-term effects of digitalis on resting and posthandgrip hemodynamics in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901.PUB2